PLD
51
-5
AEE
61
-2
EMN
70
-2
TDC
47
-2
GOOG
63
2
BAC
39
-2
APD
42
-2
IR
69
-2
HPQ
62
2
NUE
50
3
FOX
39
2
AMT
58
-2
AVY
54
-14
ECL
69
-3
TGT
50
2
WDC
49
-3
SLG
66
4
MSFT
54
-3
GRMN
50
-2
KMI
59
2
PLD
51
-5
AEE
61
-2
EMN
70
-2
TDC
47
-2
GOOG
63
2
BAC
39
-2
APD
42
-2
IR
69
-2
HPQ
62
2
NUE
50
3
FOX
39
2
AMT
58
-2
AVY
54
-14
ECL
69
-3
TGT
50
2
WDC
49
-3
SLG
66
4
MSFT
54
-3
GRMN
50
-2
KMI
59
2
Financhill
Back

Arrowhead Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
20

ARWR
Arrowhead Pharmaceuticals

Last Price:
21.14
Seasonality Move:
6.36%
Sell
33

BMRN
Biomarin Pharmaceutical

Last Price:
71.43
Seasonality Move:
5.7%
Sell
20
Arrowhead Pharmaceuticals (ARWR) is a Sell

Is Arrowhead Pharmaceuticals a Buy, Sell or Hold?

  • The current Arrowhead Pharmaceuticals [ARWR] share price is $20.78. The Score for ARWR is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ARWR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
33
Biomarin Pharmaceutical (BMRN) is a Sell

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $71.14. The Score for BMRN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARWR Stock Price Chart

What is Arrowhead Pharmaceuticals's stock price today?

  • The Arrowhead Pharmaceuticals share price today is $20.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARWR is experiencing slight buying pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $71.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

ARWR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.2 Sell
Relative Strength Index (14 RSI): 38.46 Sell
Chaikin Money Flow: 358727 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.28 - 24.28) Sell
Bollinger Bands (100): (22.65 - 26.99) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 22.64 Sell
Chaikin Money Flow: 871265 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (80.02 - 93.28) Sell
Bollinger Bands (100): (78.57 - 88.29) Sell

ARWR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.89 Sell
20-day SMA: 22.72 Sell
50-day SMA: 24.98 Sell
200-day SMA: 27.23 Sell
8-day EMA: 21.06 Sell
20-day EMA: 22.26 Sell
50-day EMA: 23.83 Sell
200-day EMA: 26.5 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 79.35 Sell
20-day SMA: 85.57 Sell
50-day SMA: 85.93 Sell
200-day SMA: 87.02 Sell
8-day EMA: 77.71 Sell
20-day EMA: 82.86 Sell
50-day EMA: 84.86 Sell
200-day EMA: 86.16 Sell

Arrowhead Pharmaceuticals Earnings Growth & ARWR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.51 per share, an increase next quarter of $0.05 per share, a decrease this year of $3.09 per share, and an increase next year of $0.08 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.

Arrowhead Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):